Literature DB >> 22138514

Functional characterization of CD4+ T cells in aplastic anemia.

Shahram Kordasti1, Judith Marsh, Sufyan Al-Khan, Jie Jiang, Alexander Smith, Azim Mohamedali, Pilar Perez Abellan, Caroline Veen, Benedetta Costantini, Austin G Kulasekararaj, Nana Benson-Quarm, Thomas Seidl, Syed A Mian, Farzin Farzaneh, Ghulam J Mufti.   

Abstract

The role of CD4(+) T cells in the pathogenesis of aplastic anemia (AA) is not well characterized. We investigate CD4(+) T-cell subsets in AA. Sixty-three patients with acquired AA were studied. Th1 and Th2 cells were significantly higher in AA patients than in healthy donors (HDs; P = .03 and P = .006). Tregs were significantly lower in patients with severe AA than in HDs (P < .001) and patients with non-severe AA (P = .01). Th17 cells were increased in severe AA (P = .02) but normal in non-severe AA. Activated and resting Tregs were reduced in AA (P = .004; P = .01), whereas cytokine-secreting non-Tregs were increased (P = .003). Tregs from AA patients were unable to suppress normal effector T cells. In contrast, AA effector T cells were suppressible by Tregs from HDs. Th1 clonality in AA, investigated by high-throughput sequencing, was greater than in HDs (P = .03). Our results confirm that Th1 and Th2 cells are expanded and Tregs are functionally abnormal in AA. The clonally restricted expansion of Th1 cells is most likely to be antigen-driven, and induces an inflammatory environment, that exacerbate the functional impairment of Tregs, which are reduced in number.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138514     DOI: 10.1182/blood-2011-08-368308

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  The diagnosis and treatment of aplastic anemia: a review.

Authors:  Maurizio Miano; Carlo Dufour
Journal:  Int J Hematol       Date:  2015-04-03       Impact factor: 2.490

2.  Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice.

Authors:  Junping Xin; Peter Breslin; Wei Wei; Jing Li; Rafael Gutierrez; Joseph Cannova; Allen Ni; Grace Ng; Rachel Schmidt; Haiyan Chen; Vamsi Parini; Paul C Kuo; Ameet R Kini; Patrick Stiff; Jiang Zhu; Jiwang Zhang
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

3.  Antithymocyte globulin combined with cyclosporine A down-regulates T helper 1 cells by modulating T cell immune response cDNA 7 in aplastic anemia.

Authors:  Feng Zhu; Jianlin Qiao; Xiao-min Zhong; Qing-yun Wu; Wei Chen; Yao Yao; Ming-shan Niu; Chun-ling Fu; Ling-yu Zeng; Zhen-yu Li; Kai-lin Xu
Journal:  Med Oncol       Date:  2015-06-07       Impact factor: 3.064

4.  Mechanism of immunosuppressants combined with cord blood for severe aplastic anemia.

Authors:  Zhe Yu; Fang Zhou; Lin-Fu Ge; Xi-Min Liu; Yuan Fang; Lin-Na Xie; Fan-Sheng Kong; Ning-Xia Song; Qing-Qing Yu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  Model-Based Determination of Effective Blood Concentrations of Cyclosporine for Neutrophil Response in the Treatment of Severe Aplastic Anemia in Children.

Authors:  Michaël Philippe; Emilie Hénin; Yves Bertrand; Dominique Plantaz; Sylvain Goutelle; Nathalie Bleyzac
Journal:  AAPS J       Date:  2015-05-15       Impact factor: 4.009

6.  Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.

Authors:  Jin Hayakawa; Junya Kanda; Yu Akahoshi; Naonori Harada; Kazuaki Kameda; Tomotaka Ugai; Hidenori Wada; Yuko Ishihara; Koji Kawamura; Kana Sakamoto; Masahiro Ashizawa; Miki Sato; Kiriko Terasako-Saito; Shun-Ichi Kimura; Misato Kikuchi; Rie Yamazaki; Shinichi Kako; Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2017-01-11       Impact factor: 2.490

7.  Immune suppression for childhood acquired aplastic anemia and myelodysplastic syndrome: where next?

Authors:  Sujith Samarasinghe; Judith Marsh; Carlo Dufour
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

8.  Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction.

Authors:  Shok Ping Lim; Benedetta Costantini; Syed A Mian; Pilar Perez Abellan; Shreyans Gandhi; Marc Martinez Llordella; Juan Jose Lozano; Rita Antunes Dos Reis; Giovanni A M Povoleri; Thanos P Mourikis; Ander Abarrategi; Linda Ariza-McNaughton; Susanne Heck; Jonathan M Irish; Giovanna Lombardi; Judith C W Marsh; Dominique Bonnet; Shahram Kordasti; Ghulam J Mufti
Journal:  Blood       Date:  2020-08-13       Impact factor: 22.113

9.  The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome.

Authors:  Benedetta Costantini; Shahram Y Kordasti; Austin G Kulasekararaj; Jie Jiang; Thomas Seidl; Pilar Perez Abellan; Azim Mohamedali; Nicolas Shaun B Thomas; Farzin Farzaneh; Ghulam J Mufti
Journal:  Haematologica       Date:  2012-12-14       Impact factor: 9.941

10.  High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.

Authors:  Christopher J Gamper; Clifford M Takemoto; Allen R Chen; Heather J Symons; David M Loeb; James F Casella; Amy E Dezern; Karen E King; Andrea M McGonigle; Richard J Jones; Robert A Brodsky
Journal:  J Pediatr Hematol Oncol       Date:  2016-11       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.